SCOTUS grants cert in ACCA cases to address prior drug convictions as predicates for 15-year mandatory minimum
As predicted in this recent post, the Supreme Court today in this morning’s SCOTUS order list granted cert in a pair of cases (which were consolidated) raising another question regarding the application of the Armed Career Criminal Act’s mandatory minimum 15-year prison term for illegal gun possession. The cases are Brown v. US, No. 22-6389 and Jackson v. US, No. 22-6640, and here are links to the Brown cert petition and the Jackson cert petition. Here is the “Question Presented” from the Brown petition:
The Armed Career Criminal Act provides that felons who possess a firearm are normally subject to a maximum 10-year sentence. But if the felon already has at least three “serious drug offense” convictions, then the minimum sentence is fifteen years.
Courts decide whether a prior state conviction counts as a serious drug offense using the categorical approach. That requires determining whether the elements of a state drug offense are the same as, or narrower than those of its federal counterpart. If so, the state conviction qualifies as an ACCA predicate.
But federal drug law often changes — as here, where Congress decriminalized hemp, narrowing the federal definition of marijuana. If state law doesn’t follow suit, sentencing courts face a categorical conundrum. Under an earlier version of federal law, the state and federal offenses match — and the state offense is an ACCA predicate. Under the amended version, the offenses do not match — and the state offense is not an ACCA predicate. So the version of federal law that the court chooses to consult dictates the difference between serving a 10-year maximum or a 15-year minimum.
The question presented is:
Which version of federal law should a sentencing court consult under ACCA’s categorical approach?
UPDATE: A helpful reader made sure I did not overlook the fact that a different drug is at issue in the Jackson case. At issue in that case is the status of a conviction that came before 2015 when “the federal government removed ioflupane I123 from the federal drug schedules.”